← All diseases
Liver, kidneys and digestion
Fatty liver disease (MASH/NASH), advanced
Do you want to receive a message when there is new research about Liver Fat (MASH/NASH), advanced? This is possible with an account. Create a free account or log in.
Automatically tracked from PubMed and ClinicalTrials.gov, newest on top. Nothing ever disappears here: what you keep in your favorites remains findable. · RSS feed of this disease · only the strongest evidence
Read in plain language what each study is about? With Premium, a single sentence appears above each publication explaining what was studied — and you'll be notified as soon as new research on Liver Steatosis (MASH/NASH), Advanced is available. View what Premium costs.
Publications and studies (2550)
- Protective Effect of α-Linolenic Acid on Non-Alcoholic Hepatic Steatosis and Interleukin-6 and -10 in Wistar Rats. (2019/12/18) ♡
- Hepatic metabolomics and transcriptomics to study susceptibility to ketosis in response to prepartal nutritional management. (2019/12/18) ♡
- Discordant pathological diagnosis of non-alcoholic fatty liver disease: A prospective multicenter study. (2019/12/17) ♡
- Effects of XIAP on high fat diet-induced hepatic steatosis: a mechanism involving NLRP3 inflammasome and oxidative stress. (2019/12/16) ♡
- Systematic reviewiAll research on one question is searched according to fixed rules and compared side by side, so that no studies with poor outcomes are missed. Evaluation of Dietary Approaches for the Treatment of Non-Alcoholic Fatty Liver Disease: A Systematic Review. (2019/12/16) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Nonalcoholic Fatty Liver Disease Induced by High-Fat Diet in C57bl/6 Models. (2019/12/16) ♡
- Cirrhosis: Diagnosis and Management. (2019/12/15) ♡
- [Peculiarities of heart risk in patients with non-alcoholic fatty liver disease]. (2019/12/15) ♡
- Non-alcoholic fatty liver disease and enteral insufficiency: comorbidity of their development. (2019/12/15) ♡
- Renalase Attenuates Mouse Fatty Liver Ischemia/Reperfusion Injury through Mitigating Oxidative Stress and Mitochondrial Damage via Activating SIRT1. (2019/12/14) ♡
- Helminthostachys zeylanica alleviates hepatic steatosis and insulin resistance in diet-induced obese mice. (2019/12/13) ♡
- Laboratory or animal researchiNo research in humans yet. Promising in a test tube or in mice unfortunately means nothing for patients. Sarcopoterium spinosum Inhibited the Development of Non-Alcoholic Steatosis and Steatohepatitis in Mice. (2019/12/13) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Moderate Alcohol Intake in Non-Alcoholic Fatty Liver Disease: To Drink or Not to Drink? (2019/12/13) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Non-alcoholic fatty liver disease (NAFLD) in non-obese individuals. (2019/12/13) ♡
- Bone morphogenetic protein 4 (BMP4) alleviates hepatic steatosis by increasing hepatic lipid turnover and inhibiting the mTORC1 signaling axis in hepatocytes. (2019/12/12) ♡
- Resveratrol Treatment Enhances the Cellular Response to Leptin by Increasing OBRb Content in Palmitate-Induced Steatotic HepG2 Cells. (2019/12/12) ♡
- Plant Sterol Ester of α-Linolenic Acid Attenuates Nonalcoholic Fatty Liver Disease by Rescuing the Adaption to Endoplasmic Reticulum Stress and Enhancing Mitochondrial Biogenesis. (2019/12/12) ♡
- Weight Gain and De Novo Metabolic Disorders after Liver Transplantation. (2019/12/10) ♡
- Up-Regulated MicroRNA-27b Promotes Adipocyte Differentiation via Induction of Acyl-CoA Thioesterase 2 Expression. (2019/12/10) ♡
- LB100 ameliorates nonalcoholic fatty liver disease via the AMPK/Sirt1 pathway. (2019/12/07) ♡
- Liver disease referrals to an urban, hospital-based hepatology outpatient clinic over the past 25 years. (2019/12/05) ♡
- Laboratory or animal researchiNo research in humans yet. Promising in a test tube or in mice unfortunately means nothing for patients. Green Tea Prevents NAFLD by Modulation of miR-34a and miR-194 Expression in a High-Fat Diet Mouse Model. (2019/12/04) ♡
- Lean non-alcoholic fatty liver disease: do not forget diabetes. (2019/12/02) ♡
- Non-alcoholic fatty liver disease in patients with inflammatory bowel disease might boost cardiovascular disease burden. (2019/12/02) ♡
- Meta-analysisiAll studies on one question combined and calculated together. This is the strongest form of research that exists: a single loose study can be coincidence, dozens together much less so. The label says something about the design, not about the outcome — which can also be that something does NOT work. A systematic review and a dose-response meta-analysis of coffee dose and nonalcoholic fatty liver disease. (2019/12/01) ♡
- Effects of Eriobotrya japonica Water Extract on Alcoholic and Nonalcoholic Fatty Liver Impairment. (2019/12/01) ♡
- MiR-218-XOR-ROS Pathway Regulates the Progression of Nonalcoholic Steatohepatitis. (2019/12/01) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Diabetes and Fatty Liver. (2019/12/01) ♡
- Imaging Fibrogenesis in a Diet-Induced Model of Nonalcoholic Steatohepatitis (NASH). (2019/12/01) ♡
- Beneficial Effects of Low-Calorie-Carbohydrate/High-Agar Diet on Cardiometabolic Disorders Associated with Non-Alcoholic Fatty Liver Disease in Obese Rats. (2019/12/01) ♡
- Commentary or editorialiAn expert's opinion or commentary, not new research. Prof. Silvia Sookoian: knowledge on the natural history and the pathogenesis of non-alcoholic fatty liver disease has incremented exponentially. (2019/12/01) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Applying Non-Invasive Fibrosis Measurements in NAFLD/NASH: Progress to Date. (2019/12/01) ♡
- Commentary or editorialiAn expert's opinion or commentary, not new research. New insights into the association between non-alcoholic fatty liver disease and atherosclerosis. (2019/12/01) ♡
- Effect of folate supplementation on immunological and autophagy markers in experimental nonalcoholic fatty liver disease. (2019/12/01) ♡
- Lotus Seedpod Extracts Reduced Lipid Accumulation and Lipotoxicity in Hepatocytes. (2019/11/28) ♡
- Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Elevated liver enzyme levels; not exclusive to liver disease. (2019/11/28) ♡
- Effect of Helicobacter pylori-eradication therapy on hepatic steatosis in patients with non-alcoholic fatty liver disease: a randomized-controlled pilot study. (2019/11/25) ♡
- Mitochondrial metabolomic profiling for elucidating the alleviating potential of Polygonatum kingianum against high-fat diet-induced nonalcoholic fatty liver disease. (2019/11/21) ♡
- [Etiological analysis of hepatopathy of unknown etiology in 470 cases undergoing routine liver biopsy examination]. (2019/11/20) ♡
- Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Prevalence of non-alcoholic fatty liver disease and hypercholesterolemia in patients with gallstone disease undergoing laparoscopic cholecystectomy. (2019/11/15) ♡
- Laboratory or animal researchiNo research in humans yet. Promising in a test tube or in mice unfortunately means nothing for patients. Pcsk9 knockout exacerbates diet-induced non-alcoholic steatohepatitis, fibrosis and liver injury in mice. (2019/11/05) ♡
- Endoscopic duodenal mucosal resurfacing improves glycaemic and hepatic indices in type 2 diabetes: 6-month multicentre results. (2019/11/05) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Lifestyle modification in NAFLD/NASH: Facts and figures. (2019/11/05) ♡
- Sodium-glucose cotransporter 2 inhibition does not reduce hepatic steatosis in overweight, insulin-resistant patients without type 2 diabetes. (2019/11/05) ♡
- Laboratory or animal researchiNo research in humans yet. Promising in a test tube or in mice unfortunately means nothing for patients. Maslinic acid protects against obesity-induced nonalcoholic fatty liver disease in mice through regulation of the Sirt1/AMPK signaling pathway. (2019/11/01) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. REVIEW - Contemporary evidence on the dynamic role of probiotics in liver diseases. (2019/11/01) ♡
- Proteome Dynamics from Heavy Water Metabolic Labeling and Peptide Tandem Mass Spectrometry. (2019/11/01) ♡
- Effects of Salvia mil on Th17 cells and related cytokines in non-alcoholic fatty liver disease. (2019/11/01) ♡
- Why we need to curb the emerging worldwide epidemic of nonalcoholic fatty liver disease. (2019/11/01) ♡
- Laboratory or animal researchiNo research in humans yet. Promising in a test tube or in mice unfortunately means nothing for patients. Lipidomic Analysis of the Protective Effects of Shenling Baizhu San on Non-Alcoholic Fatty Liver Disease in Rats. (2019/10/31) ♡
codex.care does not provide medical advice. Always discuss symptoms, medication, and treatment choices with your own healthcare provider.